Human cytomegalovirus gene products US2 and US11 differ in their ability to attack major histocompatibility class I heavy chains in dendritic cells.
about
A glycosylated type I membrane protein becomes cytosolic when peptide: N-glycanase is compromised.Surface downregulation of major histocompatibility complex class I, PE-CAM, and ICAM-1 following de novo infection of endothelial cells with Kaposi's sarcoma-associated herpesvirus.Exploitation of herpesvirus immune evasion strategies to modify the immunogenicity of human mesenchymal stem cell transplants.Kaposi's sarcoma-associated herpesvirus K3 and K5 ubiquitin E3 ligases have stage-specific immune evasion roles during lytic replicationModulation of human mesenchymal stem cell immunogenicity through forced expression of human cytomegalovirus us proteins.Human cytomegalovirus protein pp71 disrupts major histocompatibility complex class I cell surface expression.Inhibition of HLA-DR assembly, transport, and loading by human cytomegalovirus glycoprotein US3: a novel mechanism for evading major histocompatibility complex class II antigen presentation.Binding of human cytomegalovirus US2 to major histocompatibility complex class I and II proteins is not sufficient for their degradation.Placental extravillous cytotrophoblasts persistently express class I major histocompatibility complex molecules after human cytomegalovirus infection.Natural killer cell receptors for major histocompatibility complex class I and related molecules in cytomegalovirus infection.Human cytomegalovirus US2 causes similar effects on both major histocompatibility complex class I and II proteins in epithelial and glial cellsViral modulation of antigen presentation: manipulation of cellular targets in the ER and beyond.Mechanisms of MHC class I-restricted antigen processing and cross-presentation.Human cytomegalovirus microRNA miR-US4-1 inhibits CD8(+) T cell responses by targeting the aminopeptidase ERAP1Pathogen evasion strategies for the major histocompatibility complex class I assembly pathway.Functional characterization of chimpanzee cytomegalovirus chemokine, vCXCL-1(CCMV)Manipulation of dendritic cell functions by human cytomegalovirus.Diverse immune evasion strategies by human cytomegalovirus.The human cytomegalovirus US10 gene product delays trafficking of major histocompatibility complex class I molecules.Susceptibility of immature and mature Langerhans cell-type dendritic cells to infection and immunomodulation by human cytomegalovirus.The role of BiP in endoplasmic reticulum-associated degradation of major histocompatibility complex class I heavy chain induced by cytomegalovirus proteins.Dissection of the interaction of the human cytomegalovirus-derived US2 protein with major histocompatibility complex class I molecules: prominent role of a single arginine residue in human leukocyte antigen-A2.Identification of cytomegalovirus-specific cytotoxic T lymphocytes in vitro is greatly enhanced by the use of recombinant virus lacking the US2 to US11 region or modified vaccinia virus Ankara expressing individual viral genes.Feeling manipulated: cytomegalovirus immune manipulation.Immunology. Antigen processing takes a new direction.Modelling cytomegalovirus replication patterns in the human host: factors important for pathogenesis.
P2860
Q24535941-3A115B08-7296-4C24-8282-BAB00F692031Q30311122-24973D42-DD8B-4260-AF59-30B195F8F34CQ33799067-785DA617-B516-4C51-89E4-C035DA1383ADQ34059252-710531D8-04B4-459C-A7D6-2C9452973FECQ34292404-FCC060FE-F733-4D6F-9FAC-59B5219909E5Q34301906-ECF0C653-3BF8-4E3E-861A-6F46973290A6Q34349848-EA1CDA12-64F8-49CC-B103-3C5F3254D251Q35000791-DC6FA068-DA78-42FA-A498-CCEA5FE7E16AQ35155130-273DDCEC-C769-4A38-8B54-C82F7FC41EDDQ35678024-24FAF630-4368-430A-A2DE-E4AB3B0B0636Q35803399-9685EC8B-D22D-40A5-B2FD-AF82A9E4BD52Q36266461-9AED96BF-07DB-412D-842D-1353696F70A8Q36266466-40A8FFD6-4A9F-433D-9F52-3D10E1AB1AD2Q36479743-FCB8C5B9-C819-4A6C-90B3-5D714E524200Q37088488-EA669401-0ECA-4EA9-9310-54E58AF184ADQ37149865-2673A2A2-9C7C-4884-8D5D-2EB82934E3F1Q37331842-D2D4A05C-B4A0-4360-B293-0128F75609A0Q37997733-1EE7CF55-9A7B-4721-85F3-64DB4414F81FQ39685833-A7EADEC8-B5A3-4D6B-A363-ADBFE3CBB6AFQ39787577-684EB90C-193E-44B2-81C4-DF25A38B017FQ40274580-1A2E148C-1322-4D07-943B-FD63C67ECC3AQ40321837-5818384C-EFD9-4AD7-A548-51FC2034F72EQ41057170-4C16E692-8842-4032-AE0E-049E0CFC54DEQ43085159-375C0663-C421-437C-BCB9-03591160ED4BQ43903479-2FED2FFB-6792-4AC8-B6DB-1C6434D0EAEAQ51724721-119DA455-1BBE-4697-99AB-AC403B64BC31
P2860
Human cytomegalovirus gene products US2 and US11 differ in their ability to attack major histocompatibility class I heavy chains in dendritic cells.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Human cytomegalovirus gene pro ...... avy chains in dendritic cells.
@en
Human cytomegalovirus gene pro ...... avy chains in dendritic cells.
@nl
type
label
Human cytomegalovirus gene pro ...... avy chains in dendritic cells.
@en
Human cytomegalovirus gene pro ...... avy chains in dendritic cells.
@nl
prefLabel
Human cytomegalovirus gene pro ...... avy chains in dendritic cells.
@en
Human cytomegalovirus gene pro ...... avy chains in dendritic cells.
@nl
P2093
P2860
P1433
P1476
Human cytomegalovirus gene pro ...... avy chains in dendritic cells.
@en
P2093
Armin Rehm
Arne Engelsberg
Hidde L Ploegh
Ida J Körner
Insa Lehmann
Uta E Höpken
P2860
P304
P356
10.1128/JVI.76.10.5043-5050.2002
P407
P577
2002-05-01T00:00:00Z